Whats new in regulatory science

Office of Translational Sciences (OTS) – CDER

Promotes and Protects Public Health by:

  • scientific collaboration and innovation in drug regulatory review
  • validity of clinical trial design and analysis
  • quantitative and statistical approaches to decision making
  • alignment of CDER research with CDER goals
  • establishing technology transfer agreements
  • knowledge management databases
  • bioequivalence inspections


Office of Biostatistics

Office of Computational Science

Office of Clinical Pharmacology

Office of Study and Integrity and Surveillance


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account.
Log Out / 
Change )

Google photo

You are commenting using your Google account.
Log Out / 
Change )

Twitter picture

You are commenting using your Twitter account.
Log Out / 
Change )

Facebook photo

You are commenting using your Facebook account.
Log Out / 
Change )

Connecting to %s